10-K Filing

Company

Alzamend Neuro, Inc.

Filed

July 22, 2025

Period of Report

April 30, 2025

Accession Number

0001214659-25-010763

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →